ANTISENSE MODULATION OF HUMAN FXR EXPRESSION

Details for Australian Patent Application No. 2002361638 (hide)

Owner ISIS PHARMACEUTICALS, INC.

Inventors MONIA, Brett, P.; WATT, Andrew, T.

Pub. Number AU-A-2002361638

PCT Number PCT/US02/36691

PCT Pub. Number WO2003/044167

Priority 10/002,491 15.11.01 US

Filing date 13 November 2002

Wipo publication date 10 June 2003

Event Publications

10 April 2003 Complete Application Filed

  Priority application(s): 10/002,491 15.11.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-A-2002361638

29 July 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002361639-ANTISENSE MODULATION OF VITAMIN D NUCLEAR RECEPTOR EXPRESSION

2002361637-Method of verifying entitlement to participate in a gaming event from a remote location